NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals Revenue and Competitors

Location

#1336

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals's estimated annual revenue is currently $5M per year.(i)
  • NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals's estimated revenue per employee is $77,500

Employee Data

  • NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals has 65 Employees.(i)
  • NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals grew their employee count by 10% last year.

NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals's People

NameTitleEmail/Phone
1
Workforce DirectorReveal Email/Phone
2
Business Development DirectorReveal Email/Phone
3
Communications ManagerReveal Email/Phone
4
Laboratory Operations ManagerReveal Email/Phone
5
Scientific Project ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$79.1M5100%N/AN/A
#2
$0.9M620%N/AN/A
#3
$1.9M129%N/AN/A
#4
$5.4M3521%N/AN/A
#5
$0.8M5-29%N/AN/A
#6
$8.7M5624%N/AN/A
#7
$1.4M9-31%N/AN/A
#8
$1.1M70%N/AN/A
#9
$36M23219%N/AN/A
#10
$15.5M100-2%N/AN/A
Add Company

What Is NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals?

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry. NIIMBL is part of Manufacturing USA®, a diverse network of federally-sponsored manufacturing innovation institutes, and is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce with significant additional support from its members.

keywords:N/A

N/A

Total Funding

65

Number of Employees

$5M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals News

2022-04-13 - 2022-04-19 | NYSE:A | Press Release | Agilent Technologies ...

... Joins the National Institute for Innovation in Manufacturing to ... The NIIMBL mission is to accelerate biopharmaceutical innovation,...

2022-04-13 - Agilent Joins the National Institute for Innovation in ...

The NIIMBL mission is to accelerate biopharmaceutical innovation, ... and train a world-leading biopharmaceutical manufacturing workforce,...

2022-03-30 - NIIMBL eXperience Program Returns In Person with New ...

NEWARK, Del., April 5, 2022 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has selected...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12M652%N/A
#2
$7M65-6%N/A
#3
$15M653%$4.8M
#4
$15.8M6512%N/A
#5
$5M6510%N/A